ARTICLE | Clinical News
BioSpecifics regulatory update
May 17, 1999 7:00 AM UTC
The FDA advised BSTC that it must submit to the agency within 30 days a plan of corrective action related to Good Manufacturing Practices violations noted in the FDA’s recent inspection of BSTC’s faci...